Investment in Hoth Therapeutics, Inc.	3 Months Ended
Mar. 31, 2019
Investment In Hoth Therapeutics Inc.
Investment in Hoth Therapeutics, Inc.	Note 5. Investment in Hoth Therapeutics, Inc. On February 20, 2019, Hoth closed its initial public offering (“IPO) of 1,250,000 shares of its common stock at an initial offering price to the public of $5.60 per share. All shares of common stock were offered by Hoth. In February 2019, the Company purchased 35,714 shares of Hoth’s common stock for a total value of $0.2 million. The Company records this investment at fair value and records any change in fair value in the statements of operations (see Note 6). The Company owns 1,735,714 shares of Hoth common shares as of March 31, 2019. The fair value of Hoth common shares as of March 31, 2019 was $8.9 million based on the closing price of $5.15 reported on The Nasdaq Capital Market as of March 31, 2019.

Investment in Hoth Therapeutics, Inc.

3 Months Ended

Mar. 31, 2019

Investment In Hoth Therapeutics Inc.

Note 5. Investment in Hoth Therapeutics, Inc.

On February 20, 2019, Hoth closed its initial public offering (“IPO) of 1,250,000 shares of its common stock at an initial offering price to the public of $5.60 per share. All shares of common stock were offered by Hoth.

In February 2019, the Company purchased 35,714 shares of Hoth’s common stock for a total value of $0.2 million.

The Company records this investment at fair value and records any change in fair value in the statements of operations (see Note 6).

The Company owns 1,735,714 shares of Hoth common shares as of March 31, 2019. The fair value of Hoth common shares as of March 31, 2019 was $8.9 million based on the closing price of $5.15 reported on The Nasdaq Capital Market as of March 31, 2019.